Because recent studies have indicated that tissue plasminogen activator (tP
A) aggravates neurodegenerative processes in many neural pathologies, we st
udied whether the endogenous tPA antagonist neuroserpin has a neuroprotecti
ve effect in an animal model of focal ischemic stroke. After induction of a
focal ischemic stroke in the mouse by occlusion of the midddle cerebral ar
tery, we found that microglial cells accumulated in the marginal zone of th
e infarct are the most important source for both plasminogen activators, tP
A and uPA. To investigate the effect of neuroserpin on the size and the his
tology of the infarct we produced transgenic mice overexpressing neuroserpi
n approximately sixfold in the nervous system. In the brain of these mice t
he total tPA activity in the uninjured tissue was strongly reduced. After i
nduction of a focal ischemic stroke in the transgenic mice by a permanent o
cclusion of the middle cerebral artery (MCA), the infarcts were 30% smaller
than in the wild-type mice. Immunohistochemical analyses and in situ hybri
dization revealed an attenuation of the microglial activation in the reacti
ve zone. Concomitantly, the microglial production of tPA and uPA, as well a
s the PA-activity in the infarct region was markedly reduced. Thus, our res
ults indicate that neuroserpin reduces microglial activation and, therefore
, the PA activity and has a neuroprotective role after focal ischemic strok
e.